13F 机构持仓

Nextech Invest Ltd.

Zurich V8 · SEC CIK 0001595430

2026Q22026Q1 更早 9 个季度 🔒
$21.07亿2026Q2 申报市值
15持仓数
98.0%前十大占比 · 第一大 67.6%
2 / 4新建仓 / 清仓
申报市值走势$21.07亿2026Q2
26Q126Q2

付费方案可看全部 11 个季度的走势 🔒

前十大持仓 占组合比例

RVMD 67.6%
PBLS 6.1%
RLAY 6.0%
TYRA 5.4%
ALMS 4.7%
ORIC 3.7%
KYMR 1.5%
ZYME 1.4%
GLUE 0.9%
ARVN 0.8%

2026Q2 买入最多 按季末市值估算

PBLS 新建仓+$1.28亿
RLAY 加仓+$2,338.75万
GLUE 加仓+$1,105.74万
ARVN 加仓+$889.49万
ENGENE THERAPEUT 新建仓+$402.22万

2026Q2 卖出最多 按季末市值估算

TNGX 清仓-$1.52亿
CGEM 清仓-$1,621.57万
TYRA 减仓-$1,604.27万
ENGENE HOLDINGS 清仓-$1,583.29万
SPRY 清仓-$490.39万

2026Q2 持仓明细 点表头排序

导出 CSV 🔒
代码名称市值 ▲占比股数变动股数变动估算买卖额操作
TNGX TANGO THERAPEUTICS INC $00.00%0 -7,266,081-100.0% -$1.52亿 清仓
CGEM CULLINAN THERAPEUTICS INC $00.00%0 -1,141,145-100.0% -$1,621.57万 清仓
— ENGENE HOLDINGS INC $00.00%0 -2,324,943-100.0% -$1,583.29万 清仓
SPRY ARS PHARMACEUTICALS INC $00.00%0 -610,703-100.0% -$490.39万 清仓
— ENGENE THERAPEUTICS INC $402.22万0.19%2,324,943 2,324,943— $402.22万 新建仓
— CONTEXT THERAPEUTICS INC $410.96万0.20%7,419,355 00.0% — 不变
CRVS CORVUS PHARMACEUTICALS INC $672.30万0.32%450,000 00.0% — 不变
SLN SILENCE THERAPEUTICS PLC $1,045.74万0.50%952,400 00.0% — 不变
CTMX CYTOMX THERAPEUTICS INC. $1,668.72万0.79%4,449,932 00.0% — 不变
ARVN ARVINAS INC $1,712.00万0.81%1,122,713 583,319108.1% $889.49万 加仓
GLUE MONTE ROSA THERAPEUTICS INC $1,841.99万0.87%761,153 456,916150.2% $1,105.74万 加仓
ZYME ZYMEWORKS INC $2,911.85万1.38%1,113,946 00.0% — 不变
KYMR KYMERA THERAPEUTICS INC $3,198.10万1.52%278,896 00.0% — 不变
ORIC ORIC PHARMACEUTICALS INC $7,757.14万3.68%7,162,637 00.0% — 不变
ALMS ALUMIS INC $9,964.37万4.73%3,540,998 00.0% — 不变
TYRA TYRA BIOSCIENCES INC $1.14亿5.39%3,553,585 -502,276-12.4% -$1,604.27万 减仓
RLAY RELAY THERAPEUTICS INC $1.27亿6.02%6,776,506 1,250,00022.6% $2,338.75万 加仓
PBLS PARABILIS MEDICINES INC $1.28亿6.06%4,663,176 4,663,176— $1.28亿 新建仓
RVMD REVOLUTION MEDICINES INC $14.24亿67.55%7,601,087 00.0% — 不变